Regeneron Pharmaceuticals (REGN) News Today $634.14 -26.86 (-4.06%) Closing price 04:00 PM EasternExtended Trading$632.83 -1.31 (-0.21%) As of 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025March 25 at 4:05 PM | globenewswire.comIs Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Extremely Profitable Stocks to Buy According to Analyst?March 25 at 10:34 AM | insidermonkey.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Corebridge Financial Inc.Corebridge Financial Inc. lowered its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 5.0% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 34,652 shares of the biopharmaceutical company's stock after selling 1March 25 at 6:31 AM | marketbeat.comVanguard Group Inc. Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Vanguard Group Inc. reduced its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 0.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,286,346 sharesMarch 25 at 5:44 AM | marketbeat.comLawsuit Notice: Investors who hold Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares should contact the Shareholders FoundationMarch 24 at 11:13 PM | globenewswire.comSimplify Asset Management Inc. Lowers Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Simplify Asset Management Inc. lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 34.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 6,258 shares of the biopharmaceutical company's stock afMarch 24 at 6:18 AM | marketbeat.comKLP Kapitalforvaltning AS Makes New $34.47 Million Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)KLP Kapitalforvaltning AS purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 48,388 shares of the biopMarch 24 at 5:49 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Mizuho Securities USA LLCMizuho Securities USA LLC increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 45.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,977 shares of the biopharmaceutical company's stock aMarch 24 at 5:25 AM | marketbeat.comAXQ Capital LP Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)AXQ Capital LP trimmed its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 69.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 382 shares of the biopharmaceutical company's stock after selling 873 shares during theMarch 24 at 5:18 AM | marketbeat.comForefront Wealth Management Inc. Acquires New Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Forefront Wealth Management Inc. purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 3,097 shares of the biopharmaceuticalMarch 23 at 6:34 AM | marketbeat.comAmerican Century Companies Inc. Sells 30,949 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)American Century Companies Inc. reduced its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 4.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 707,546 shares of the biopharmaceutical company's stock after selling 30,949 shaMarch 23 at 6:33 AM | marketbeat.comVirtu Financial LLC Has $3.06 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Virtu Financial LLC lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 29.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,294 shares of the biopharmaceuMarch 23 at 6:09 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Summit Global InvestmentsSummit Global Investments cut its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 14.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 10,114 shares of the biopharmaceutical company's stock after selling 1,754 shares dMarch 23 at 5:49 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Teacher Retirement System of TexasTeacher Retirement System of Texas grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 32.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 38,932 shares of the biopharmaceutical company's stock after acquiring an adMarch 23 at 4:57 AM | marketbeat.comMadison Investment Advisors LLC Takes $4.59 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Madison Investment Advisors LLC acquired a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 6,445 shares of tMarch 23 at 3:53 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. cut its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 95.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 934 shares of the biopharmaceutical company's stock after sellMarch 23 at 3:44 AM | marketbeat.comDCF Advisers LLC Has $6.34 Million Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)DCF Advisers LLC lifted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 14.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,900 shares of the biopharmaceutical company's stock after acqMarch 22 at 6:05 AM | marketbeat.comCommonwealth of Pennsylvania Public School Empls Retrmt SYS Cuts Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Commonwealth of Pennsylvania Public School Empls Retrmt SYS decreased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 3.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The instituMarch 22 at 5:22 AM | marketbeat.comiA Global Asset Management Inc. Decreases Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)iA Global Asset Management Inc. lessened its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 11.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 11,648 shares of the biopharmaceutical company's stock after selling 1,53March 22 at 5:21 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Royal London Asset Management Ltd.Royal London Asset Management Ltd. grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 0.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 44,084 shares of the bioMarch 22 at 5:11 AM | marketbeat.comAdvisors Asset Management Inc. Sells 443 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Advisors Asset Management Inc. lessened its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 7.9% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,165 shares of the biopharmaceutical company's stock afterMarch 22 at 4:36 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Position Increased by Envestnet Portfolio Solutions Inc.Envestnet Portfolio Solutions Inc. raised its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 36.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,684 shares of the bMarch 22 at 4:02 AM | marketbeat.com3 Reasons to Sell REGN and 1 Stock to Buy InsteadMarch 21, 2025 | msn.comBlueshift Asset Management LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Blueshift Asset Management LLC lifted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 284.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,303 shares of the biopharmaceutical companyMarch 21, 2025 | marketbeat.comMagnetar Financial LLC Has $77.04 Million Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Magnetar Financial LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 1,445.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 108,150 shares of the biopharmacMarch 21, 2025 | marketbeat.comVinva Investment Management Ltd Buys 1,182 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Vinva Investment Management Ltd increased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 45.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor oMarch 21, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Sees Significant Growth in Short InterestRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Get Free Report) was the recipient of a large growth in short interest in February. As of February 28th, there was short interest totalling 2,570,000 shares, a growth of 16.8% from the February 13th total of 2,200,000 shares. Approximately 2.5% of the shares of the stock are sold short. Based on an average daily trading volume, of 916,800 shares, the days-to-cover ratio is presently 2.8 days.March 20, 2025 | marketbeat.comKazazian Asset Management LLC Invests $399,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Kazazian Asset Management LLC purchased a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 560 shares of the biopharmaceutical company's sMarch 20, 2025 | marketbeat.comHarvest Fund Management Co. Ltd Acquires 1,366 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Harvest Fund Management Co. Ltd grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 27.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,360 shares of the bioMarch 20, 2025 | marketbeat.comXponance Inc. Has $11.59 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Xponance Inc. lifted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 3.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,272 shares of the biopharmaceutical company'sMarch 20, 2025 | marketbeat.comThrivent Financial for Lutherans Has $89.18 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Thrivent Financial for Lutherans boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 1,272.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 125,194 shares of the bioMarch 20, 2025 | marketbeat.comCorient Private Wealth LLC Sells 4,349 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Corient Private Wealth LLC lessened its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 16.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,884 shares of the biMarch 20, 2025 | marketbeat.comAvantax Advisory Services Inc. Purchases 404 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Avantax Advisory Services Inc. grew its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 33.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,624 sMarch 20, 2025 | marketbeat.comGenerali Asset Management SPA SGR Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Generali Asset Management SPA SGR bought a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 11,358 shares of the bMarch 19, 2025 | marketbeat.comCommonwealth Equity Services LLC Trims Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Commonwealth Equity Services LLC trimmed its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 5.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 18,014 shares of the biopharmaceutical company's stock afterMarch 19, 2025 | marketbeat.comRegeneron Pharmaceuticals (REGN): Among the Best Biotech Stocks to Buy According to BillionairesMarch 18, 2025 | msn.comNikko Asset Management Americas Inc. Sells 2,730 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Nikko Asset Management Americas Inc. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 9.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 26,154 shares of the bMarch 18, 2025 | marketbeat.comCibc World Markets Corp Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Cibc World Markets Corp increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 13.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 19,153 shares of the biopharmaceutical company's stock after buying an additional 2,201 shaMarch 18, 2025 | marketbeat.comRegeneron Pharmaceuticals (NasdaqGS:REGN) Shares Dip 1% Despite Positive Dupixent Trial ResultsMarch 18, 2025 | finance.yahoo.comJim Cramer Wants You to ‘Own’ Regeneron Pharmaceuticals (REGN) SharesMarch 17, 2025 | insidermonkey.comNatixis Advisors LLC Sells 7,064 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Natixis Advisors LLC trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 6.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 109,938 shares of the biopharmaceuticalMarch 17, 2025 | marketbeat.com500 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Intact Investment Management Inc.Intact Investment Management Inc. purchased a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 500 shares of the biopharmaceutical company's stock, valuMarch 17, 2025 | marketbeat.comGreykasell Wealth Strategies Inc. Buys Shares of 708 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Greykasell Wealth Strategies Inc. purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 708 shares of the biopharmaceuticalMarch 16, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Position Trimmed by Achmea Investment Management B.V.Achmea Investment Management B.V. lessened its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 90.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor ownMarch 16, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by AGF Management Ltd.AGF Management Ltd. lifted its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 281.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,277 sharesMarch 16, 2025 | marketbeat.comHighTower Advisors LLC Cuts Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)HighTower Advisors LLC lessened its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 8.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,302 shares of the biophaMarch 16, 2025 | marketbeat.comRegeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Down 1.8% - What's Next?Regeneron Pharmaceuticals (NASDAQ:REGN) Shares Down 1.8% - Here's What HappenedMarch 15, 2025 | marketbeat.comRegeneron stock dips as court denies Eylea patent stayMarch 14, 2025 | au.investing.comEylea biosimilar injunction denial ‘negative’ for Regeneron, says UBSMarch 14, 2025 | markets.businessinsider.comRegeneron falls after appeals court ruling in Eylea caseMarch 14, 2025 | msn.com Remove Ads Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address REGN Media Mentions By Week REGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REGN News Sentiment▼1.430.62▲Average Medical News Sentiment REGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REGN Articles This Week▼3526▲REGN Articles Average Week Remove Ads Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Vertex Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News BioMarin Pharmaceutical News Incyte News Neurocrine Biosciences News Exelixis News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REGN) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy REGN Stock Free REGN Stock Alerts